Skip to main content
SpringerLink
Log in

Polyuric Syndromes

  • Chapter
Therapy of Renal Diseases and Related Disorders

  • 130 Accesses

Abstract

Rational therapy of polyuric syndromes requires understanding of the disordered physiology, in particular, knowledge of body water metabolism and the renal concentrating mechanism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beri T, Anderson RJ, McDonald KM, et al: Clinical disorders of water metabolism. Kidney Int 10: 117, 1976.

    Article  Google Scholar 

  2. Earley LE: Extreme polyima in obstructive uropathy: Report of case of ‘water-losing nephritis’ in infant with discussion of polyuria. N Engl J Med 255: 600, 1956.

    Article  PubMed  CAS  Google Scholar 

  3. Wilson DR: Pathophysiology of obstructive nephropathy. Kidney Int 18: 281, 1980.

    Article  PubMed  CAS  Google Scholar 

  4. Arieff AI, Guisado R: Effects on the central nervous system of hypematremic and hyponatremic states. Kidney Int 10: 104, 1976.

    Article  PubMed  CAS  Google Scholar 

  5. Arief AI, Guisado R, Lazarowitz VC: The pathophysiology of hyperosmolar states. In: Andreoli TE, Grantham JJ, Rector FC Jr (eds) Disturbances in Body Fluid Osmolality. For the American Physiological Society. Baltimore, Williams & Wilkins, 1977, p 227.

    Google Scholar 

  6. Barlow ED, de Wardener HE: Compulsive water drinking. Q J Med 28: 235, 1959.

    PubMed  CAS  Google Scholar 

  7. Beri T, Unas S, Ainsenbrey G, et al. On the mechanism of polyuria in potassium depletion. The role of polydipsia. J Clin Invest 60: 620, 1977.

    Article  Google Scholar 

  8. Blotner H: Primary or idiopathic diabetes insipidus: A systemic disease. Metabolism 7: 191, 1958.

    PubMed  CAS  Google Scholar 

  9. Coggins CH, Leaf A: Diabetes insipidus. Am J Med 42: 807, 1967.

    Article  PubMed  CAS  Google Scholar 

  10. Miller M, Dalakos T, Moses AM et al: Recognition of partial defects in antidiuretic hormone secretion. Ann Intem Med 73: 721, 1970.

    CAS  Google Scholar 

  11. Robinson MG, Kaplan SA: Inheritance of vasopressin- resistant (‘nephrogenic’) diabetes insipidus. Am J Dis Child 99: 164, 1960.

    CAS  Google Scholar 

  12. Silverstein E, Tobian L: Pitressin-resistant diabetes insipidus with massive hydronephrosis. Am J Med 30: 819, 1961.

    Article  Google Scholar 

  13. Carter RD, Goodman AD: Nephrogenic diabetes insipidus accompanied by massive dilation of the kidneys, ureters, and bladder. J Urol 89: 366, 1963.

    PubMed  CAS  Google Scholar 

  14. Fichman MP, Brooker G: Deficient renal cyclic adenosine 3′, 5′-monophosphate production in nephrogenic diabetes insipidus. J Clin Endocrinol Metab 35: 35, 1972.

    Article  PubMed  CAS  Google Scholar 

  15. Tannen RL, Regal EM, Dunn MJ,et al: Vasopressin-resistant hyposthenuria in advanced chronic renal disease. N Engl J Med 280: 1135, 1969.

    Article  PubMed  CAS  Google Scholar 

  16. Sheam MA, Tu W: Nephrogenic diabetes insipidus and other defects of renal tubular function in Sjogren’s syndrome. Am J Med 39: 312, 1965.

    Article  Google Scholar 

  17. Carone FA, Epstein FH: Nephrogenic diabetes insipidus caused by amyloid disease: Evidence in man of role of collecting ducts in concentrating urine. Am J Med 29: 539, 1960.

    Article  PubMed  CAS  Google Scholar 

  18. Smithline N, Kassirer J, Cohen JJ: Light-chain nephropathy, tubular dysfunction and light-chain proteinuria. N Engl J Med 294: 71, 1976.

    Article  PubMed  CAS  Google Scholar 

  19. Holliday MA, Egar TJ, Morris CR, et al: Vasopressin resistant hyposthenuria in chronic renal disease. Am J Med 42: 378, 1967.

    Article  PubMed  CAS  Google Scholar 

  20. Levitt MF, Hausser AD, Levy MS, et al: The renal concentrating defect in sickle cell disease. Am J Med 29: 611, 1960.

    Article  PubMed  CAS  Google Scholar 

  21. Buckalew VM, Jr, Someren A: Renal manifestations of sickle cell disease. Arch Intem Med 133: 660, 1974.

    Article  Google Scholar 

  22. Singer I, Forrest JV: Drug-induced states of nephrogenic diabetes insipidus. Kidney Int 10: 82, 1976.

    Article  PubMed  CAS  Google Scholar 

  23. Singer I, Rotenberg D, Puschett JB: Lithium-induced nephrogenic diabetes insipidus in vivo and in vitro studies. J Clin Invest 51: 1081, 1972.

    Article  PubMed  CAS  Google Scholar 

  24. Cox M, Singh I: Lithium and water metabolism. Am J Med 59: 153, 1975.

    Article  PubMed  CAS  Google Scholar 

  25. Singer I, Rotenberg D: Demeclocycline-induced nephrogenic diabetes insipidus. Ann Intem Med 79: 679, 1973.

    CAS  Google Scholar 

  26. Douglas JB, Healy JK: Nephrotoxic effects of amphotericin B, including renal tubular acidosis. Am J Med 46: 154, 1969.

    Article  PubMed  CAS  Google Scholar 

  27. Mazze RI, Shue GL, Jackson SH: Renal dysfunction associated with methoxyflurane anesthesia. JAMA 216: 278, 1971.

    Article  PubMed  CAS  Google Scholar 

  28. Bower BF, Wegienka LC, Forsham PM: In vitro studies of the mechanism of polyuria induced by dextropropoxy- phene (Darvon). Proc Soc Exp Biol Med 120: 155, 1965.

    PubMed  CAS  Google Scholar 

  29. Dousa TP, Bames LD: Effects of colchicine and vinblastine on the cellular action of vasopressin in mammalian kidney. A possible role of microtubules. J Clin Invest 54: 252, 1974.

    Article  PubMed  CAS  Google Scholar 

  30. Bed T, Cadnapaphomchai P, Harbottle JA, et al: Mechanism of suppression of vasopressin during alpha adrenergic stimulation with norepinephrine. J Clin Invest 53: 219, 1974.

    Article  Google Scholar 

  31. Mannitius A et al: On the mechanism of impairment of renal concentrating ability in hypercalcemia. J Clin Invest 39: 693, 1960.

    Article  Google Scholar 

  32. Zeffren JL, Heinemann HO: Reversible defect in renal concentrating mechanism in patients with hypercalcemia. Am J Med 33: 54, 1962.

    Article  PubMed  CAS  Google Scholar 

  33. Beck N, Singh H, Reed E, et al: Pathogenic role of cyclic AMP in the impairment of urinary concentrating ability in acute hypercalcemia. J Clin Invest 54: 1049, 1974.

    Article  PubMed  CAS  Google Scholar 

  34. Manitius A, Levitin H, Beck D, et al: On the mechanism of impairment of renal concentrating ability in potassium deficiencies. J Clin Invest 39: 684, 1960.

    Article  PubMed  CAS  Google Scholar 

  35. Kim JK, Schrier RW, Berl T: Effect of hypokalemia on renal medullary cyclic AMP generation, metabolism and action (abstract). Clin Res 27: 420A, 1979.

    Google Scholar 

  36. Rado JP, Maros J, Borbely L: Individual differences in antidiuretic response induced by DDAVP in diabetes insipidus. Hormone Metab Res 8: 155, 1976.

    Article  CAS  Google Scholar 

  37. Miller M, Moses AM: Drug-induced states of impaired water excretion in mammalian kidney. Kidney Int 10: 38, 1976.

    Article  PubMed  Google Scholar 

  38. Froyshov I, Haugen HN: Chlorpropamide treatment in diabetes insipidus. Acta Med Scand 183: 397, 1968.

    Article  PubMed  CAS  Google Scholar 

  39. Rado JP: Combination of carbamazepine and chlorpropamide in the treatment of ‘hyporesponders’ pituitary diabetes insipidus. J Clin Endocrinal Metab 38: 1, 1974.

    Article  CAS  Google Scholar 

  40. Wales JK: Treatment of diabetes insipidus with carbamazepine. Lancet 2:948, 1975,

    Google Scholar 

Download references

Authors
  1. Douglas R. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Bernard J. Hanley, Los Angeles, CA, 90033, USA

    Wadi N. Suki M.D. (Professor of Medicine Professor of Physiology and Biophysics Chief) (Professor of Medicine Professor of Physiology and Biophysics Chief)

  2. Division of Nephrology, University of Southern California School of Medicine, Los Angeles, CA, 90033, USA

    Wadi N. Suki M.D. (Professor of Medicine Professor of Physiology and Biophysics Chief) (Professor of Medicine Professor of Physiology and Biophysics Chief)

  3. Renal Section Baylor College of Medicine, The Methodist Hospital, Houston, TX, 77030, USA

    Shaul G. Massry M.D. (Professor of Medicine and Physiology Chief) (Professor of Medicine and Physiology Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishing, Boston/ The Hague/ Dordrecht/ Lancaster

About this chapter

Cite this chapter

Wilson, D.R. (1984). Polyuric Syndromes. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3807-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3807-9_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3809-3

  • Online ISBN: 978-1-4613-3807-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation